CARDIOPSYCHIATRY. A CLASH OF OPINIONS
https://doi.org/10.15829/1728-8800-2017-2-84-87
Abstract
The article is focused on the novel and former psychiatric disorders (PD) classification in cardiopsychiatry. Novel classification relates PD to the mechanisms of stress. It takes into consideration that stress mechanisms might influence the risk of development and/or progression of cardiovascular diseases (CVD). Former classification is based upon the list of hardly related terms and includes doubtful and outdated diagnoses. It does not explain the pathways of PD influence of CVD. The traditional and recent viewpoints are considered in PD, as the drugs prescription. In a range of cases, PD develop due to neuronal activity dysfunction, hence the selection of drug relates on its ability to influence these disorders. In other cases PD pathogenesis is not known, and drugs are prescribed with unknown influence on neuronal activity.
About the Author
M. Yu. Drobizhev
I.M. Sechenov First Moscow State Medical University of the Ministry of Health
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Drobizhev MY, Kikta SV, Machilskaya OV. Сardiopsychiatry. Problems of translation. Cardiovascular Therapy and Prevention 2016; 15(4): 88-97. DOI:10.15829/1728-8800-2016-4-88-97. Russian (Дробижев М.Ю., Кикта С.В., Мачильская О.В. Кардиопсихиатрия. Проблемы перевода. Кардиоваскулярная терапия и профилактика 2016; 15(4): 88-97. DOI:10.15829/1728-8800-2016-4-88-97).
2. Farr OM, Ko BJ, Joung KE, et al. Posttraumatic stress disorder, alone or additively with early life adversity, is associated with obesity and cardiometabolic risk. Nutr Metab Cardiovasc Dis 2015; 25(5): 479-88.
3. Kershaw KN, Brenes GA, Charles LE, et al. Associations of stressful life events and social strain with incident cardiovascular disease in the Women’s Health Initiative. J Am Heart Assoc 2014; 3(3): e000687.
4. Husarewycz MN, El-Gabalawy R, Logsetty S, et al. The association between number and type of traumatic life experiences and physical conditions in a nationally representative sample. Gen Hosp Psychiatry 2014; 36(1): 26-32.
5. Celano CM, Millstein RA, Bedoya CA, et al. Association between anxiety and mortality in patients with coronary artery disease: A meta-analysis. Am Heart J 2015; 170(6): 1105-15.
6. Mental and behavioral disorders (F00 — F99) Class V of ICD-10, adapted for use in the Russian Federation Moscow 1998 http://psychiatr.ru/download/1320?view=1&name=МКБ-10+адаптированный+для+РФ+1998.pdf. (29 November 2016) Russian (Психические расстройства и расстройства поведения (F00 — F99) Класс V МКБ-10, адаптированный для использования в Российской Федерации Москва 1998 http://psychiatr.ru/download/1320?view=1&name=МКБ-10+адаптированный+для+РФ+1998.pdf.).
7. Golimbet VE, Volel’ BA, Korovaĭtseva GI, Dolzhikov AV. Depression comorbid to ischemic heart disease: a psychometric and molecular-genetic study. Journal of Neurology and psychistarii im.S.S.Korsakova 2015; 115(2): 42-7. DOI: 10.17116/jnevro20151152142-47. Russian (Голимбет В.Е., Волель Б.А., Коровайцева Г.И., Должиков А.В. Коморбидная ишемической болезни сердца депрессия: психометрическое и молекулярно-генетическое исследование. Журнал неврологии и психиатрии им. С.С. Корсакова 2015;115(2):42-7. DOI: 10.17116/jnevro20151152142-47).
8. Šmigelskas K, Žemaitienė N, Julkunen J, Kauhanen J. Type A behavior pattern is not a predictor of premature mortality. Int J Behav Med 2015; 22(2): 161-9. doi: 10.1007/s12529-014-9435-1.
9. Kim DA, McClure WG 3rd, Neighoff JB, et al. Platelet response to serotonin in patients with stable coronary heart disease. Am J Cardiol 2014; 114(2): 181-6.
10. Alevizos M, Karagkouni A, Panagiotidou S, et al. Stress triggers coronary mast cells leading to cardiac events. Ann Allergy Asthma Immunol 2014; 112(4): 309-16.
11. Mostofsky E, Penner EA, Mittleman MA. Outbursts of anger as a trigger of acute cardiovascular events: a systematic review and meta-analysis. Eur Heart J 2014; 35(21): 1404-10.
12. Steptoe A, Kivimäki M. Stress and cardiovascular disease. Nat Rev Cardiol 2012; 9(6): 360-70.
13. Wybraniec M, Mizia-Stec K, Krzych L. Stress cardiomyopathy: yet another type of neurocardiogenic injury: ‘stress cardiomyopathy’. Cardiovasc Pathol 2014; 23(3): 113-20.
14. Stahl SM. Stahl’s essential psychopharmacology: neuroscientific basis and practical application. 3nd ed. Cambridge University Press 2008; 1117 p.
15. Morrissette DA, Stahl SM. Modulating the serotonin system in the treatment of major depressive disorder. CNS Spectr 2014; 19 Suppl 1: 57-67; quiz 54-7, 68. doi: 10.1017/S1092852914000613.
16. Velaxin. Instruction for medical use of the drug. http://medi.ru/doc/a02104.htm. (29 November 2016) Russian (Велаксин. Инструкция по медицинскому применению препарата. http://medi.ru/doc/a02104.htm.)
17. Cymbalta. Instruction for medical use of the drug. http://medi.ru/doc/2508.htm. (29 November 2016) Russian (Симбалта. Инструкция по медицинскому применению препарата (информация для специалистов) http://medi.ru/doc/2508.htm.)
18. Valdoxan. Instruction for medical use of the drug. http://medi.ru/doc/f4216.htm. (29 November 2016) Russian (Вальдоксан. Инструкция по медицинскому применению препарата http://medi.ru/doc/f4216.htm).
Review
For citations:
Drobizhev M.Yu. CARDIOPSYCHIATRY. A CLASH OF OPINIONS. Cardiovascular Therapy and Prevention. 2017;16(2):84-87. (In Russ.) https://doi.org/10.15829/1728-8800-2017-2-84-87
Views:
905
Email this article 
